BNP Paribas Financial Markets’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86.3K Sell
65,398
-657
-1% -$1.18K ﹤0.01% 4448
2025
Q4
$124K Buy
66,055
+7,729
+13% +$14.9K ﹤0.01% 4279
2025
Q3
$74.7K Buy
58,326
+21,864
+60% +$29.6K ﹤0.01% 4429
2025
Q2
$45.2K Sell
36,462
-7,359
-17% -$8.5K ﹤0.01% 4295
2025
Q1
$51.7K Sell
43,821
-327,047
-88% -$502K ﹤0.01% 4280
2024
Q4
$679K Sell
370,868
-291,860
-44% -$570K ﹤0.01% 3083
2024
Q3
$1.13M Sell
662,728
-341,387
-34% -$561K ﹤0.01% 2423
2024
Q2
$1.38M Sell
1,004,115
-163,593
-14% -$330K ﹤0.01% 2112
2024
Q1
$4.38M Buy
1,167,708
+584,734
+100% +$3.42M 0.01% 1544
2023
Q4
$5.72M Buy
582,974
+2,832
+0.5% +$23.2K 0.01% 1322
2023
Q3
$4.84M Buy
580,142
+40,924
+8% +$468K 0.01% 1293
2023
Q2
$7.17M Buy
539,218
+430,177
+395% +$5.23M 0.01% 1054
2023
Q1
$1.26M Buy
109,041
+61,742
+131% +$614K ﹤0.01% 2166
2022
Q4
$387K Sell
47,299
-51,656
-52% -$445K ﹤0.01% 2716
2022
Q3
$574K Buy
98,955
+25,515
+35% +$146K ﹤0.01% 2888
2022
Q2
$325K Buy
73,440
+24,890
+51% +$151K ﹤0.01% 2877
2022
Q1
$442K Sell
48,550
-33,385
-41% -$384K ﹤0.01% 2812
2021
Q4
$1.68M Sell
81,935
-5,447
-6% -$131K ﹤0.01% 2190
2021
Q3
$2.23M Buy
87,382
+67,860
+348% +$2.01M 0.01% 1826
2021
Q2
$683K Sell
19,522
-23,646
-55% -$688K ﹤0.01% 2389
2021
Q1
$1.44M Buy
43,168
+9,484
+28% +$332K ﹤0.01% 1904
2020
Q4
$874K Sell
33,684
-5,146
-13% -$87.4K ﹤0.01% 2109
2020
Q3
$383K Buy
38,830
+33,488
+627% +$193K ﹤0.01% 2378
2020
Q2
$18.4K Sell
5,342
-42,845
-89% -$146K ﹤0.01% 3430
2020
Q1
$147K Sell
48,187
-668,506
-93% -$2.74M ﹤0.01% 3014
2019
Q4
$3.68M Buy
716,693
+694,484
+3,127% +$3.53M 0.01% 1360
2019
Q3
$115K Sell
22,209
-919,422
-98% -$5.14M ﹤0.01% 3056
2019
Q2
$5.7M Buy
941,631
+906,343
+2,568% +$6.36M 0.02% 980
2019
Q1
$255K Buy
+35,288
New +$255K ﹤0.01% 2552
2018
Q4
Sell
-5,377
Closed -$29.1K 4398
2018
Q3
$29.1K Buy
5,377
+1,128
+27% +$4.84K ﹤0.01% 3257
2018
Q2
$15.1K Sell
4,249
-24,034
-85% -$66.7K ﹤0.01% 3609
2018
Q1
$58K Buy
28,283
+6,063
+27% +$15.7K ﹤0.01% 3486
2017
Q4
$58.7K Buy
22,220
+13,774
+163% +$48.2K ﹤0.01% 3577
2017
Q3
$44.3K Sell
8,446
-604
-7% -$2.6K ﹤0.01% 3205
2017
Q2
$32.2K Buy
9,050
+8,540
+1,675% +$34.4K ﹤0.01% 3411
2017
Q1
$2.64K Sell
510
-885
-63% -$4.33K ﹤0.01% 3464
2016
Q4
$5.3K Sell
1,395
-4,155
-75% -$30.2K ﹤0.01% 3682
2016
Q3
$49.7K Buy
5,550
+2,589
+87% +$21.6K ﹤0.01% 2433
2016
Q2
$20.8K Buy
+2,961
New +$27K ﹤0.01% 2573
2016
Q1
Sell
-11,514
Closed -$151K 2964
2015
Q4
$151K Sell
11,514
-1,378
-11% -$12.4K ﹤0.01% 2105
2015
Q3
$47.2K Buy
12,892
+7,853
+156% +$38.4K ﹤0.01% 2908
2015
Q2
$29K Buy
5,039
+3,684
+272% +$21.3K ﹤0.01% 2823
2015
Q1
$7.91K Buy
1,355
+1,354
+135,400% +$9.34K ﹤0.01% 2881
2014
Q4
$8 Sell
1
-3,792
-100% -$24.3K ﹤0.01% 1964
2014
Q3
$18.6K Buy
3,793
+3,653
+2,609% +$19.1K ﹤0.01% 3221
2014
Q2
$865 Buy
140
+139
+13,900% +$696 ﹤0.01% 3468
2014
Q1
$4 Sell
1
-620
-100% -$3.92K ﹤0.01% 3368
2013
Q4
$3.25K Sell
621
-176,770
-100% -$812K ﹤0.01% 3372
2013
Q3
$979K Sell
177,391
-7,120
-4% -$24.7K ﹤0.01% 1148
2013
Q2
$465K Buy
+184,511
New +$459K ﹤0.01% 1617

Other funds holding PACB